With a closing date of 5pm on Tuesday 4th August 2015 the National Institute for Health & Care Excellence are looking for a patient or carer member to join a NICE committee partially updating the NICE clinical guidelines on Crohn’s disease: management in adults, children and young people.
For this PARTIAL Update of the Guideline work NICE are seeking applications from people with knowledge and experience of being treated with infliximab (sometimes known by the brand name ‘Remicade’) or adalimumab (sometimes known by the brand name ‘Humira’) in combination with immunosuppressants (which are medicines to suppress the immune system).
You will see that children and young people are covered by the NICE Guidance and this upcoming PARTIAL Update.
An attendance fee is provided and expenses are covered for lay members.
However the closing date is Tuesday 4 August 2015 at 5pm and this date is now fast approaching so if you would like to apply please go to the NICE website http://nice.org.uk where you will find full details of the recruitment. This includes links to the paperwork needed to apply for the role.
If you, or anyone you know, has any queries about this NICE lay member position, please do get in touch directly with:
Public Involvement Adviser
Public Involvement Programme
National Institute for Health and Care Excellence
Level 1A | City Tower | Piccadilly Plaza | Manchester M1 4BT | United Kingdom
Tel: +44 (0) 161 219 3889
E-mail to: Jessica.Fielding@nice.org.uk]
NICE really values the contribution that patients, service users, carers and those who advocate for them make to the guidance that we produce – without it, the National institute for Health and Care Excellence – NICE’s work could not be relevant for the people most directly affected by their guidance.
While CICRA have been asked to share the information in this message, if interested please reply direct to Jess Fielding at NICE: Jessica.Fielding@nice.org.uk